Rankings
▼
Calendar
TEVA Q2 2016 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$35B
Q2 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$5.0B
Gross Profit
$2.9B
57.1% margin
Operating Income
$361M
7.2% margin
Net Income
$254M
5.0% margin
EPS (Diluted)
$0.28
QoQ Revenue Growth
+4.7%
Cash Flow
Operating Cash Flow
$963M
Free Cash Flow
$788M
Stock-Based Comp.
$28M
Balance Sheet
Total Assets
$57.9B
Total Liabilities
$25.9B
Stockholders' Equity
$30.1B
Cash & Equivalents
$7.0B
← FY 2016
All Quarters
Q3 2016 →
